In brief
Norwegian Crown Princess Mette‑Marit was successfully transplanted with a lung in Oslo after a four‑year battle with pulmonary fibrosis. The procedure was carried out at Oslo University Hospital with specialist Are Holm praising the outcome. The princess will remain in hospital for several weeks under observation. The transplant follows her son Marius Holby's prison conviction and earlier statements on her deteriorating health. Experts advise that post‑transplant care will require lifelong immunosuppression and a careful recovery.
Norway’s Crown Princess Mette‑Marit has undergone a successful lung transplant in Oslo, announced the royal household.
She was diagnosed with a rare form of pulmonary fibrosis in 2018, and her condition deteriorated over recent months.
Lung specialist Are Holm praised the operation and noted that the princess will remain in hospital for several weeks for observation, a standard practice for transplant recipients.
Prince Haakon will adjust his official schedule to support her.
The transplant follows two days after her son Marius Borg Høiby was sentenced to four years in prison for two counts of rape, a situation that highlighted the family's personal challenges.
Experts emphasize that recovery will be delicate; transplant recipients require lifelong immunosurgery medication and face a significant risk in the first year after surgery.
The procedure comes against a backdrop of other recent events involving the royal family, including a 2021 apology by Mette‑Marit for her earlier friendship with Jeffrey Epstein.
